Avricore Health's subsidiary HealthTab has integrated with UK-based HeartEye's AI retinal cardiovascular risk assessment, enabling patients flagged at risk during optician visits to be referred to nearby pharmacies for further testing and care. This new pathway allows pharmacists to perform cholesterol tests and calculate comprehensive cardiovascular risk, supporting NHS goals to shift care from hospitals to community settings and enhance prevention. The integration also aligns with new pharmacist prescribing rights in England, potentially enabling treatment initiation in pharmacies. Avricore will showcase this solution at The Pharmacy Show 2026, aiming to expand community-based health screening and care access.
HealthTab and HeartEye integration is the subject, with Pluang data providing market context. As of Oct 08, 2026 17:11 WIB, 28 of 100 health-sector US stocks rose while 65 fell. Notable movers include DNA at USD 11.21 (-2.27%), ABEO at USD 5.18 (+1.97%), and ALNY at USD 220.02 (-1.96%).
Dividend 15 Split Corp. has renewed its at-the-market (ATM) equity program, allowing it to issue shares to the public at prevailing market prices until November 7, 2028. This program replaces the previous one that ended in 2025 and enables the compan...
Fieldstone Bio, a synthetic biology company, was selected for the Mining Tech Accelerator program by Founders Factory and Rio Tinto. The program supports innovative technologies that improve mineral exploration and extraction, providing Fieldstone wi...
Beam Global has signed a definitive agreement to acquire ScoutDI, a company specializing in drone technology and AI-powered inspection software. The acquisition will enable Beam to manufacture ScoutDI's drone systems in the US and Europe, targeting i...
Grabar Law Office is investigating shareholder claims against four companies—Aardvark Therapeutics, Coastal Financial Corporation, Erasca, Inc., and New Era Energy & Digital—for alleged securities violations and breaches of fiduciary duties. The clai...
Visa Canada's data reveals that the Toronto International Film Festival (TIFF) 2026 increased visitor spending by 12% compared to 2025, with international visitors spending about 40% more than Canadian cardholders. The festival attracted visitors mai...
